StockGuru Blog: The Immune Response Corporation – Multiple Sclerosis Important Advancements Phase IIb Clinical Trials Scheduled
IMNR - The Immune Response CorporationImportant Phase IIb Trials Set to Begin for MS Treatment - NeuroVax NeuroVax Phase IIb…